https://www.selleckchem.com/pr....oducts/mpp-dihydroch
70 (1.35 to 2.13), 0.97 (0.75 to 1.27), 1.80 (1.35 to 2.4, and 1.62 (1.07 to 2.45) for pad preparation, drilling, stimulation, and production metrics, respectively. We did not find effect modification by HFrEF or HFpEF status. Associations of most UNGD metrics with hospitalization were stronger among those with more severe HF at baseline. Three of 4 phases of UNGD activity were associated with hospitalization for HF in a large sample of patients with HF in an area of active UNGD, with similar findings by HFrEF versus HFpEF
Like
Comment
Share
